Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 08:30 am Sale | 13G | ENTERA BIO LTD SHS ENTX | Capital Point Ltd. | 0 0% | -1,147,385 (Position Closed) | View |
| 2021-02-16 06:11 am Sale | 13G | ENTERA BIO LTD SHS ENTX | Capital Point Ltd. | 1,147,385 5.43% | -457,435 (-28.50%) | View |
| 2020-12-10 10:58 am Sale | 13G | 9 METERS BIOPHARMA INC NMTR | Capital Point Ltd. | 7,295,893 4.81% | -82,166 (-1.11%) | View |
| 2020-09-03 5:19 pm Purchase | 13G | 9 METERS BIOPHARMA INC NMTR | Capital Point Ltd. | 7,378,059 8.07% | 7,378,059 (New Position) | View |
| 2020-02-13 09:56 am Purchase | 13G | ENTERA BIO LTD SHS ENTX | Capital Point Ltd. | 1,604,820 8.98% | 453,014 (+39.33%) | View |
| 2019-10-24 10:49 am Sale | 13D | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Capital Point Ltd. | 5,509,260 4.6% | -7,334,760 (-57.11%) | View |
| 2019-10-17 5:30 pm Unchanged | 13D | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Capital Point Ltd. | 12,844,020 10.73% | 0 (Unchanged) | View |
| 2019-09-11 4:15 pm Unchanged | 13D | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Capital Point Ltd. | 12,844,020 12.88% | 0 (Unchanged) | View |
| 2019-08-08 10:54 am Unchanged | 13D | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Capital Point Ltd. | 12,844,020 12.88% | 0 (Unchanged) | View |
| 2019-07-10 10:14 am Purchase | 13D | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Capital Point Ltd. | 12,844,020 12.88% | 873,000 (+7.29%) | View |
| 2019-06-14 08:01 am Unchanged | 13D | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Capital Point Ltd. | 11,971,020 12% | 0 (Unchanged) | View |
| 2019-06-06 10:32 am Purchase | 13D | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Capital Point Ltd. | 11,971,020 12% | 1,618,590 (+15.63%) | View |
| 2019-05-30 07:13 am Purchase | 13D | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Capital Point Ltd. | 10,352,430 10.38% | 10,352,430 (New Position) | View |